It’s never going to be a straightforward decision, but there’s a strong case for outsourcing R&D activities, particularly so for pharmaceutical companies. But how do you arrive at the right ratio for your organization?
Don’t base your decision on guesswork — let data be your guide, recommends GEP’s new white paper, Pharma R&D Outsourcing: How To Optimize Spend and Maximize ROI. It discusses the benefits of R&D outsourcing and shares a quadrant framework to help companies assess the impact of R&D investments.
What’s Inside:
- What R&D outsourcing can bring to the table
- How to assess efficiency of R&D spend and outsourcing
- Case study: How GEP helped a pharma company improve R&D productivity
This paper is a must-read for business and procurement leaders in pharma who want to make smart, impactful outsourcing decisions.
Theme: Strategy and Planning
RECOMMENDED
Featured
The Cost-Plus World of Supply Chains: The Macroeconomic and Geopolitical Environment
As geopolitical and macroeconomic concerns increase, this survey-based Economist Impact-GEP report looks at what companies are doing to manage the resultant supply chain challenges.
Case Study
How a Global CPG Company Saved 20% on Packaging Costs by Partnering With GEP
GEP helps leading U.S.-based CPG company optimize its packaging spend, improve inventory management and its forecasting capabilities.
